Elevatus Welath Management Natera, Inc. Transaction History
Elevatus Welath Management
- $366 Billion
- Q4 2025
A detailed history of Elevatus Welath Management transactions in Natera, Inc. stock. As of the latest transaction made, Elevatus Welath Management holds 1,026 shares of NTRA stock, worth $209,591. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,026Holding current value
$209,591% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
770Shares Held
127MCall Options Held
1.13MPut Options Held
417K-
Vanguard Group Inc Valley Forge, PA12.4MShares$2.53 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.9MShares$2.44 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY11.6MShares$2.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.38 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.25MShares$869 Million2.96% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $19.8B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...